MINDERA - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
90305558
Word Mark
MINDERA
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2022-02-10
Filing Date
2020-11-08
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260103 - Incomplete circles (more than semi-circles).
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
MORRIS, ALINA S.
Statements
Description of Mark
The mark consists of The word Mindera with a line forming a circle shape starting, but not touching, above the d going to the left and down and ending, but not touching, under the d.
Goods and Services
Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services
Goods and Services
Medical services; Nucleic acid sequencing and analysis services for medical purposes; Genome sequencing and analysis services for medical purposes; Medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses; Medical testing and analysis for diagnostic and treatment purposes; DNA, RNA, nucleic acid and genetic sequencing, screening, and analysis services for medical purposes; Clinical diagnostic and consultation services for medical purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-01-08
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-01-08
Primary Code
044
Correspondences
Name
Johnny F. Manriquez
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-11-11 | NEW APPLICATION ENTERED IN TRAM |
2021-01-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2021-01-09 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2021-04-14 | ASSIGNED TO EXAMINER |
2021-04-21 | NON-FINAL ACTION WRITTEN |
2021-04-21 | NON-FINAL ACTION E-MAILED |
2021-04-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-07-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-07-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-02 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-07-30 | NON-FINAL ACTION WRITTEN |
2021-07-30 | NON-FINAL ACTION E-MAILED |
2021-07-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2022-02-10 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2022-02-10 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |